• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 8 of 19
US-ECONOMY-STOCK MARKET
HealthWhy Cancer Drug Maker Incyte’s Stock Plunged—And Took Others Down With It
By Sy MukherjeeApril 6, 2018
Najin (R) and Fatu, the only two remaining female northern white rhinoceroses.
CommentaryCommentary: These Technologies Could Save the Northern White Rhino From Extinction
By Nishan Degnarain and Ryan PhelanMarch 20, 2018
The psychiatric unit of a hospital in Haute Savoie, France
HealthThe Diseases We Aren’t Curing—And Why
By Sy MukherjeeFebruary 6, 2018
A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris
HealthWhy Sanofi Is Buying Belgian Biotech Company Ablynx for Nearly $5 Billion
By ReutersJanuary 29, 2018
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By Sy MukherjeeJanuary 22, 2018
Pipetting droplets of liquid into multiwell dish, high angle view
FinanceU.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion
By ReutersJanuary 7, 2018
482179767
HealthThis Startup Wants to Democratize CRISPR Gene Editing Research By Making It Free
By Sy MukherjeeDecember 13, 2017
Bustling street of China Town in Bangkok
HealthWhy American Entrepreneurs Need to Study China’s Biotech Strategy
By Clifton LeafDecember 12, 2017
Forbes Under 30 Summit
HealthWhy SoftBank Made a Record-Breaking $1.1 Billion Bet on This Biotech Firm
By Sy MukherjeeAugust 9, 2017
US-ECONOMY-STOCK MARKET
HealthWhy the Biotech Market Has Come Roaring Back in 2017
By Sy MukherjeeAugust 4, 2017
Cystic fibrosis drug campaign
HealthThis Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail
By Sy MukherjeeJuly 19, 2017
Forbes Under 30 Summit
HealthThis 31-Year-Old CEO Is Snapping Up Drug Industry Veterans Left and Right
By Sy MukherjeeJuly 10, 2017
House GOP
HealthThis GOP Congressman Lost $17 Million on a Biotech Investment Gone Wrong
By Sy MukherjeeJune 27, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Fall
HealthWhy Cancer Biotech Clovis Oncology’s Stock Is Soaring
By Sy MukherjeeJune 19, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
HealthThis Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat
By Sy MukherjeeJune 12, 2017
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...19
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.